{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,17]],"date-time":"2026-11-17T03:58:55Z","timestamp":1794887935338,"version":"4.9.1"},"reference-count":18,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,2,20]],"date-time":"2023-02-20T00:00:00Z","timestamp":1676851200000},"content-version":"vor","delay-in-days":19,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Lung"],"published-print":{"date-parts":[[2023,2]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    This observational study assessed the prevalence of co-existing type 2 inflammatory conditions [T2Cs; asthma, atopic dermatitis (AD), allergic rhinitis, and chronic rhinosinusitis with nasal polyps (CRSwNP)] in patients with moderate-to-severe (M\/S) type 2 asthma, M\/S CRSwNP, or M\/S AD, in the real-world setting. Data from 761 physicians in the US and EUR5 were sourced from Adelphi Disease-Specific Programmes covering patients with M\/S asthma (\n                    <jats:italic>n<\/jats:italic>\n                    \u2009=\u2009899), M\/S CRSwNP (\n                    <jats:italic>n<\/jats:italic>\n                    \u2009=\u2009683), and M\/S AD (\n                    <jats:italic>n<\/jats:italic>\n                    \u2009=\u20091497). At least one T2C was identified in 66%, 69%, and 46% of M\/S asthma, M\/S CRSwNP, and M\/S AD cohorts, respectively, and 24%, 36% and 16% had at least two T2Cs; trends were similar in the US and EUR5. In patients with M\/S asthma or M\/S CRSwNP, T2Cs commonly presented as mild or moderate. The comorbidity burden suggests that an integrated treatment approach is warranted to address underlying type 2 inflammation in patients with M\/S type 2 diseases.\n                  <\/jats:p>","DOI":"10.1007\/s00408-023-00603-z","type":"journal-article","created":{"date-parts":[[2023,2,23]],"date-time":"2023-02-23T12:10:13Z","timestamp":1677154213000},"page":"57-63","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":50,"title":["Prevalence and Severity Distribution of Type 2 Inflammation-Related Comorbidities Among Patients with Asthma, Chronic Rhinosinusitis with Nasal Polyps, and Atopic Dermatitis"],"prefix":"10.1007","volume":"201","author":[{"given":"Asif H.","family":"Khan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Im\u00e8ne","family":"Gouia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siddhesh","family":"Kamat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Small","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Siddall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,2,20]]},"reference":[{"issue":"7","key":"603_CR1","doi-asserted-by":"publisher","first-page":"1582","DOI":"10.1111\/all.14318","volume":"75","author":"CA Akdis","year":"2020","unstructured":"Akdis CA, Arkwright PD, Br\u00fcggen MC, Busse W, Gadina M, Guttman-Yassky E et al (2020) Type 2 immunity in the skin and lungs. Allergy 75(7):1582\u20131605","journal-title":"Allergy"},{"issue":"6","key":"603_CR2","doi-asserted-by":"publisher","first-page":"473","DOI":"10.2500\/ajra.2013.27.3981","volume":"27","author":"MR Chaaban","year":"2013","unstructured":"Chaaban MR, Walsh EM, Woodworth BA (2013) Epidemiology and differential diagnosis of nasal polyps. Am J Rhinol Allergy 27(6):473\u2013478","journal-title":"Am J Rhinol Allergy"},{"issue":"5","key":"603_CR3","doi-asserted-by":"publisher","first-page":"1350","DOI":"10.1016\/j.jaci.2013.02.002","volume":"131","author":"BK Tan","year":"2013","unstructured":"Tan BK, Chandra RK, Pollak J, Kato A, Conley DB, Peters AT et al (2013) Incidence and associated premorbid diagnoses of patients with chronic rhinosinusitis. J Allergy Clin Immunol 131(5):1350\u20131360","journal-title":"J Allergy Clin Immunol"},{"key":"603_CR4","unstructured":"AJMC Perspectives in Type 2 Inflammation (2019) The emerging role of the type 2 inflammatory cascade in atopic diseases. Am J Manag Care"},{"issue":"1","key":"603_CR5","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.jid.2016.08.022","volume":"137","author":"PM Brunner","year":"2017","unstructured":"Brunner PM, Silverberg JI, Guttman-Yassky E, Paller AS, Kabashima K, Amagai M et al (2017) Increasing comorbidities suggest that atopic dermatitis is a systemic disorder. J Invest Dermatol 137(1):18\u201325","journal-title":"J Invest Dermatol"},{"key":"603_CR6","doi-asserted-by":"publisher","first-page":"127","DOI":"10.2147\/JAA.S290424","volume":"14","author":"C Bachert","year":"2021","unstructured":"Bachert C, Bhattacharyya N, Desrosiers M, Khan AH (2021) Burden of disease in chronic rhinosinusitis with nasal polyps. J Asthma Allergy 14:127\u2013134","journal-title":"J Asthma Allergy"},{"issue":"12","key":"603_CR7","doi-asserted-by":"publisher","first-page":"3087","DOI":"10.1111\/all.14620","volume":"75","author":"K Asano","year":"2020","unstructured":"Asano K, Ueki S, Tamari M, Imoto Y, Fujieda S, Taniguchi M (2020) Adult-onset eosinophilic airway diseases. Allergy 75(12):3087\u20133099","journal-title":"Allergy"},{"issue":"6","key":"603_CR8","doi-asserted-by":"publisher","first-page":"1495","DOI":"10.1016\/j.jaci.2019.10.023","volume":"144","author":"N Schoettler","year":"2019","unstructured":"Schoettler N, Rodriguez E, Weidinger S, Ober C (2019) Advances in asthma and allergic disease genetics: Is bigger always better? J Allergy Clin Immunol 144(6):1495\u20131506","journal-title":"J Allergy Clin Immunol"},{"issue":"11","key":"603_CR9","doi-asserted-by":"publisher","first-page":"3063","DOI":"10.1185\/03007990802457040","volume":"24","author":"P Anderson","year":"2008","unstructured":"Anderson P, Benford M, Harris N, Karavali M, Piercy J (2008) Real-world physician and patient behaviour\nacross countries: Disease-Specific Programmes - a means to understand. Curr Med Res Opin 24(11):3063\u20133072","journal-title":"Curr Med Res Opin"},{"issue":"5","key":"603_CR10","first-page":"343","volume":"57","author":"A Khan","year":"2019","unstructured":"Khan A, Huynh TMT, Vandeplas G, Joish VN, Mannent LP, Tomassen P et al (2019) The GALEN rhinosinusitis cohort: chronic rhinosinusitis with nasal polyps affects health-related quality of life. Rhinology 57(5):343\u2013351","journal-title":"Rhinology"},{"issue":"9","key":"603_CR11","doi-asserted-by":"publisher","first-page":"1969","DOI":"10.1002\/lary.27852","volume":"129","author":"N Bhattacharyya","year":"2019","unstructured":"Bhattacharyya N, Villeneuve S, Joish VN, Amand C, Mannent L, Amin N et al (2019) Cost burden and resource utilization in patients with chronic rhinosinusitis and nasal polyps. Laryngoscope 129(9):1969\u20131975","journal-title":"Laryngoscope"},{"key":"603_CR12","first-page":"45","volume":"9","author":"C Langdon","year":"2016","unstructured":"Langdon C, Mullol J (2016) Nasal polyps in patients with asthma: prevalence, impact, and management challenges. J Asthma Allergy 9:45\u201353","journal-title":"J Asthma Allergy"},{"issue":"2","key":"603_CR13","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1016\/j.anai.2019.04.020","volume":"123","author":"JI Silverberg","year":"2019","unstructured":"Silverberg JI (2019) Comorbidities and the impact of atopic dermatitis. Ann Allergy Asthma Immunol 123(2):144\u2013151","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"5","key":"603_CR14","doi-asserted-by":"publisher","first-page":"383","DOI":"10.2500\/ajra.2014.28.4076","volume":"28","author":"K H\u00e5kansson","year":"2014","unstructured":"H\u00e5kansson K, Thomsen SF, Konge L, Mortensen J, Backer V, von Buchwald C (2014) A comparative and descriptive study of asthma in chronic rhinosinusitis with nasal polyps. Am J Rhinol Allergy 28(5):383\u2013387","journal-title":"Am J Rhinol Allergy"},{"issue":"4","key":"603_CR15","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1002\/alr.21674","volume":"6","author":"C Promsopa","year":"2016","unstructured":"Promsopa C, Kansara S, Citardi MJ, Fakhri S, Porter P, Luong A (2016) Prevalence of confirmed asthma varies in chronic rhinosinusitis subtypes. Int Forum Allergy Rhinol 6(4):373\u2013377","journal-title":"Int Forum Allergy Rhinol"},{"issue":"6","key":"603_CR16","doi-asserted-by":"publisher","first-page":"1269","DOI":"10.2105\/AJPH.2014.302172","volume":"105","author":"N Bhan","year":"2015","unstructured":"Bhan N, Kawachi I, Glymour MM, Subramanian SV (2015) Time trends in racial and ethnic disparities in asthma prevalence in the United States from the behavioral risk factor surveillance system (BRFSS) study (1999\u20132011). Am J Public Health 105(6):1269\u20131275","journal-title":"Am J Public Health"},{"issue":"5","key":"603_CR17","doi-asserted-by":"publisher","first-page":"1462","DOI":"10.1016\/j.jaip.2018.10.016","volume":"7","author":"E Heffler","year":"2019","unstructured":"Heffler E, Blasi F, Latorre M, Menzella F, Paggiaro P, Pelaia G et al (2019) The severe asthma network in Italy: findings and perspectives. J Allergy Clin Immunol Pract 7(5):1462\u20131468","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"2","key":"603_CR18","doi-asserted-by":"publisher","first-page":"67","DOI":"10.4168\/aair.2011.3.2.67","volume":"3","author":"T Zheng","year":"2011","unstructured":"Zheng T, Yu J, Oh MH, Zhu Z (2011) The atopic march: progression from atopic dermatitis to allergic rhinitis and asthma. Allergy Asthma Immunol Res 3(2):67\u201373","journal-title":"Allergy Asthma Immunol Res"}],"container-title":["Lung"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00408-023-00603-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00408-023-00603-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00408-023-00603-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,25]],"date-time":"2023-02-25T09:04:47Z","timestamp":1677315887000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00408-023-00603-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2]]},"references-count":18,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023,2]]}},"alternative-id":["603"],"URL":"https:\/\/doi.org\/10.1007\/s00408-023-00603-z","relation":{},"ISSN":["0341-2040","1432-1750"],"issn-type":[{"value":"0341-2040","type":"print"},{"value":"1432-1750","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,2]]},"assertion":[{"value":"3 June 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 January 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 February 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"AHK, IG, and RJ are employees of Sanofi and own stock and\/or stock options in the company. SK is an employee of Regeneron Pharmaceuticals, Inc. and owns stock and\/or stock options in the company. MS and JS are employees of Adelphi Real World, a company that received research funding for the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"In line with Adelphi Real World Standard Operating Procedures, each Disease-Specific Programme was submitted to the Western Institutional Review Board, a central institutional review board, where ethical exemption determination was granted.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}},{"value":"All included patients provided informed consent to participate in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Participate"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Publish"}}]}}